- Home
- INTS vs PMEC Comparison
INTS vs PMEC Comparison
Compare INTS & PMEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- PMEC
- Stock Information
- Founded
- INTS 2012
- PMEC 1984
- Country
- INTS United States
- PMEC Singapore
- Employees
- INTS N/A
- PMEC 2744
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- PMEC
- Sector
- INTS Health Care
- PMEC
- Exchange
- INTS Nasdaq
- PMEC Nasdaq
- Market Cap
- INTS 33.4M
- PMEC 26.2M
- IPO Year
- INTS 2023
- PMEC 2023
- Fundamental
- Price
- INTS $2.23
- PMEC $0.69
- Analyst Decision
- INTS Strong Buy
- PMEC
- Analyst Count
- INTS 3
- PMEC 0
- Target Price
- INTS $8.50
- PMEC N/A
- AVG Volume (30 Days)
- INTS 26.6K
- PMEC 323.0K
- Earning Date
- INTS 03-13-2025
- PMEC 12-31-2024
- Dividend Yield
- INTS N/A
- PMEC N/A
- EPS Growth
- INTS N/A
- PMEC N/A
- EPS
- INTS N/A
- PMEC N/A
- Revenue
- INTS N/A
- PMEC $72,524,000.00
- Revenue This Year
- INTS N/A
- PMEC N/A
- Revenue Next Year
- INTS N/A
- PMEC N/A
- P/E Ratio
- INTS N/A
- PMEC N/A
- Revenue Growth
- INTS N/A
- PMEC 5.07
- 52 Week Low
- INTS $1.50
- PMEC $0.49
- 52 Week High
- INTS $5.94
- PMEC $4.15
- Technical
- Relative Strength Index (RSI)
- INTS 49.26
- PMEC 46.18
- Support Level
- INTS $1.84
- PMEC $0.69
- Resistance Level
- INTS $2.27
- PMEC $0.74
- Average True Range (ATR)
- INTS 0.28
- PMEC 0.08
- MACD
- INTS -0.01
- PMEC -0.00
- Stochastic Oscillator
- INTS 56.36
- PMEC 6.64
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.